These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

267 related articles for article (PubMed ID: 34916658)

  • 1. TREM2 interacts with TDP-43 and mediates microglial neuroprotection against TDP-43-related neurodegeneration.
    Xie M; Liu YU; Zhao S; Zhang L; Bosco DB; Pang YP; Zhong J; Sheth U; Martens YA; Zhao N; Liu CC; Zhuang Y; Wang L; Dickson DW; Mattson MP; Bu G; Wu LJ
    Nat Neurosci; 2022 Jan; 25(1):26-38. PubMed ID: 34916658
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Microglial TREM2 in amyotrophic lateral sclerosis.
    Xie M; Zhao S; Bosco DB; Nguyen A; Wu LJ
    Dev Neurobiol; 2022 Jan; 82(1):125-137. PubMed ID: 34874625
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The TREM2-APOE Pathway Drives the Transcriptional Phenotype of Dysfunctional Microglia in Neurodegenerative Diseases.
    Krasemann S; Madore C; Cialic R; Baufeld C; Calcagno N; El Fatimy R; Beckers L; O'Loughlin E; Xu Y; Fanek Z; Greco DJ; Smith ST; Tweet G; Humulock Z; Zrzavy T; Conde-Sanroman P; Gacias M; Weng Z; Chen H; Tjon E; Mazaheri F; Hartmann K; Madi A; Ulrich JD; Glatzel M; Worthmann A; Heeren J; Budnik B; Lemere C; Ikezu T; Heppner FL; Litvak V; Holtzman DM; Lassmann H; Weiner HL; Ochando J; Haass C; Butovsky O
    Immunity; 2017 Sep; 47(3):566-581.e9. PubMed ID: 28930663
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Triggering receptor expressed on myeloid cells 2 (TREM2) deficiency attenuates phagocytic activities of microglia and exacerbates ischemic damage in experimental stroke.
    Kawabori M; Kacimi R; Kauppinen T; Calosing C; Kim JY; Hsieh CL; Nakamura MC; Yenari MA
    J Neurosci; 2015 Feb; 35(8):3384-96. PubMed ID: 25716838
    [TBL] [Abstract][Full Text] [Related]  

  • 5. TREM2 modifies microglial phenotype and provides neuroprotection in P301S tau transgenic mice.
    Jiang T; Zhang YD; Chen Q; Gao Q; Zhu XC; Zhou JS; Shi JQ; Lu H; Tan L; Yu JT
    Neuropharmacology; 2016 Jun; 105():196-206. PubMed ID: 26802771
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Microglial transcriptome analysis in the rNLS8 mouse model of TDP-43 proteinopathy reveals discrete expression profiles associated with neurodegenerative progression and recovery.
    Hunter M; Spiller KJ; Dominique MA; Xu H; Hunter FW; Fang TC; Canter RG; Roberts CJ; Ransohoff RM; Trojanowski JQ; Lee VM
    Acta Neuropathol Commun; 2021 Aug; 9(1):140. PubMed ID: 34412701
    [TBL] [Abstract][Full Text] [Related]  

  • 7. TREM2 triggers microglial density and age-related neuronal loss.
    Linnartz-Gerlach B; Bodea LG; Klaus C; Ginolhac A; Halder R; Sinkkonen L; Walter J; Colonna M; Neumann H
    Glia; 2019 Mar; 67(3):539-550. PubMed ID: 30548312
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Loss of TREM2 rescues hyperactivation of microglia, but not lysosomal deficits and neurotoxicity in models of progranulin deficiency.
    Reifschneider A; Robinson S; van Lengerich B; Gnörich J; Logan T; Heindl S; Vogt MA; Weidinger E; Riedl L; Wind K; Zatcepin A; Pesämaa I; Haberl S; Nuscher B; Kleinberger G; Klimmt J; Götzl JK; Liesz A; Bürger K; Brendel M; Levin J; Diehl-Schmid J; Suh J; Di Paolo G; Lewcock JW; Monroe KM; Paquet D; Capell A; Haass C
    EMBO J; 2022 Feb; 41(4):e109108. PubMed ID: 35019161
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Microglial CD68 and L-ferritin upregulation in response to phosphorylated-TDP-43 pathology in the amyotrophic lateral sclerosis brain.
    Swanson MEV; Mrkela M; Murray HC; Cao MC; Turner C; Curtis MA; Faull RLM; Walker AK; Scotter EL
    Acta Neuropathol Commun; 2023 Apr; 11(1):69. PubMed ID: 37118836
    [TBL] [Abstract][Full Text] [Related]  

  • 10. TREM2 Promotes Microglial Survival by Activating Wnt/β-Catenin Pathway.
    Zheng H; Jia L; Liu CC; Rong Z; Zhong L; Yang L; Chen XF; Fryer JD; Wang X; Zhang YW; Xu H; Bu G
    J Neurosci; 2017 Feb; 37(7):1772-1784. PubMed ID: 28077724
    [TBL] [Abstract][Full Text] [Related]  

  • 11. TREM2 deficiency attenuates neuroinflammation and protects against neurodegeneration in a mouse model of tauopathy.
    Leyns CEG; Ulrich JD; Finn MB; Stewart FR; Koscal LJ; Remolina Serrano J; Robinson GO; Anderson E; Colonna M; Holtzman DM
    Proc Natl Acad Sci U S A; 2017 Oct; 114(43):11524-11529. PubMed ID: 29073081
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Amyloid-beta modulates microglial responses by binding to the triggering receptor expressed on myeloid cells 2 (TREM2).
    Zhong L; Wang Z; Wang D; Wang Z; Martens YA; Wu L; Xu Y; Wang K; Li J; Huang R; Can D; Xu H; Bu G; Chen XF
    Mol Neurodegener; 2018 Mar; 13(1):15. PubMed ID: 29587871
    [TBL] [Abstract][Full Text] [Related]  

  • 13. TREM2-dependent microglial function is essential for remyelination and subsequent neuroprotection.
    Wang Y; Kyauk RV; Shen YA; Xie L; Reichelt M; Lin H; Jiang Z; Ngu H; Shen K; Greene JJ; Sheng M; Yuen TJ
    Glia; 2023 May; 71(5):1247-1258. PubMed ID: 36625077
    [TBL] [Abstract][Full Text] [Related]  

  • 14. What happens to microglial TREM2 in Alzheimer's disease: Immunoregulatory turned into immunopathogenic?
    Lue LF; Schmitz C; Walker DG
    Neuroscience; 2015 Aug; 302():138-50. PubMed ID: 25281879
    [TBL] [Abstract][Full Text] [Related]  

  • 15. microRNA-34a-Mediated Down-Regulation of the Microglial-Enriched Triggering Receptor and Phagocytosis-Sensor TREM2 in Age-Related Macular Degeneration.
    Bhattacharjee S; Zhao Y; Dua P; Rogaev EI; Lukiw WJ
    PLoS One; 2016; 11(3):e0150211. PubMed ID: 26949937
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Trem2 deficiency impairs recovery and phagocytosis and dysregulates myeloid gene expression during virus-induced demyelination.
    Hwang M; Savarin C; Kim J; Powers J; Towne N; Oh H; Bergmann CC
    J Neuroinflammation; 2022 Nov; 19(1):267. PubMed ID: 36333761
    [TBL] [Abstract][Full Text] [Related]  

  • 17. TREM2 lipid sensing sustains the microglial response in an Alzheimer's disease model.
    Wang Y; Cella M; Mallinson K; Ulrich JD; Young KL; Robinette ML; Gilfillan S; Krishnan GM; Sudhakar S; Zinselmeyer BH; Holtzman DM; Cirrito JR; Colonna M
    Cell; 2015 Mar; 160(6):1061-71. PubMed ID: 25728668
    [TBL] [Abstract][Full Text] [Related]  

  • 18. TREM2 variant p.R47H as a risk factor for sporadic amyotrophic lateral sclerosis.
    Cady J; Koval ED; Benitez BA; Zaidman C; Jockel-Balsarotti J; Allred P; Baloh RH; Ravits J; Simpson E; Appel SH; Pestronk A; Goate AM; Miller TM; Cruchaga C; Harms MB
    JAMA Neurol; 2014 Apr; 71(4):449-53. PubMed ID: 24535663
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Triggering Receptor Expressed on Myeloid Cells-2 (TREM2) Interacts With Colony-Stimulating Factor 1 Receptor (CSF1R) but Is Not Necessary for CSF1/CSF1R-Mediated Microglial Survival.
    Cheng B; Li X; Dai K; Duan S; Rong Z; Chen Y; Lü L; Liu Z; Huang X; Xu H; Zhang YW; Zheng H
    Front Immunol; 2021; 12():633796. PubMed ID: 33841415
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Microglial membrane receptor TREM2 mediates exosome secretion to promote phagocytosis of amyloid-β by microglia.
    Huang S; Liao X; Wu J; Zhang X; Li Y; Xiang D; Luo S
    FEBS Lett; 2022 Apr; 596(8):1059-1071. PubMed ID: 35292963
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.